Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Reply to 'Comment on 'Anthropometric measurements and survival after prostate cancer diagnosis".

Farris MS, Courneya KS, Kopciuk KA, McGregor SE, Friedenreich CM.

Br J Cancer. 2018 Aug;119(4):525-526. doi: 10.1038/s41416-018-0213-8. Epub 2018 Jul 31. No abstract available.

PMID:
30061584
2.

Serum Metabolomics of Activity Energy Expenditure and its Relation to Metabolic Syndrome and Obesity.

Palmnäs MSA, Kopciuk KA, Shaykhutdinov RA, Robson PJ, Mignault D, Rabasa-Lhoret R, Vogel HJ, Csizmadi I.

Sci Rep. 2018 Feb 19;8(1):3308. doi: 10.1038/s41598-018-21585-6.

3.

Post-diagnosis alcohol intake and prostate cancer survival: A population-based cohort study.

Farris MS, Courneya KS, Kopciuk KA, McGregor SE, Friedenreich CM.

Int J Cancer. 2018 Jul 15;143(2):253-262. doi: 10.1002/ijc.31307. Epub 2018 Feb 23.

PMID:
29435976
4.

A quantitative multimodal metabolomic assay for colorectal cancer.

Farshidfar F, Kopciuk KA, Hilsden R, McGregor SE, Mazurak VC, Buie WD, MacLean A, Vogel HJ, Bathe OF.

BMC Cancer. 2018 Jan 4;18(1):26. doi: 10.1186/s12885-017-3923-z.

5.

Anthropometric measurements and survival after a prostate cancer diagnosis.

Farris MS, Courneya KS, Kopciuk KA, McGregor SE, Friedenreich CM.

Br J Cancer. 2018 Feb 20;118(4):607-610. doi: 10.1038/bjc.2017.440. Epub 2017 Dec 12.

PMID:
29235565
6.

Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.

Tudor RA, D'Silva A, Tremblay A, MacEachern P, Morris D, Brenner D, Kopciuk K, Bebb DG.

PLoS One. 2017 Aug 4;12(8):e0181867. doi: 10.1371/journal.pone.0181867. eCollection 2017.

7.

Comparison of two accelerometers for measuring physical activity and sedentary behaviour.

Pfister T, Matthews CE, Wang Q, Kopciuk KA, Courneya K, Friedenreich C.

BMJ Open Sport Exerc Med. 2017 May 12;3(1):e000227. doi: 10.1136/bmjsem-2017-000227. eCollection 2017.

8.

Performance of variable selection methods using stability-based selection.

Lu D, Weljie A, de Leon AR, McConnell Y, Bathe OF, Kopciuk K.

BMC Res Notes. 2017 Apr 4;10(1):143. doi: 10.1186/s13104-017-2461-8.

9.

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.

Thirukkumaran C, Shi ZQ, Thirukkumaran P, Luider J, Kopciuk K, Spurrell J, Elzinga K, Morris D.

PLoS One. 2017 Jan 18;12(1):e0168233. doi: 10.1371/journal.pone.0168233. eCollection 2017.

10.

Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.

McConnell YJ, Farshidfar F, Weljie AM, Kopciuk KA, Dixon E, Ball CG, Sutherland FR, Vogel HJ, Bathe OF.

Metabolites. 2017 Jan 13;7(1). pii: E3. doi: 10.3390/metabo7010003.

11.

Novel Allosteric Pathway of Eg5 Regulation Identified through Multivariate Statistical Analysis of Hydrogen-Exchange Mass Spectrometry (HX-MS) Ligand Screening Data.

Sheff JG, Farshidfar F, Bathe OF, Kopciuk K, Gentile F, Tuszynski J, Barakat K, Schriemer DC.

Mol Cell Proteomics. 2017 Mar;16(3):428-437. doi: 10.1074/mcp.M116.064246. Epub 2017 Jan 5.

12.

Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis.

Farris MS, Kopciuk KA, Courneya KS, McGregor SE, Wang Q, Friedenreich CM.

Int J Cancer. 2017 Apr 1;140(7):1517-1527. doi: 10.1002/ijc.30586. Epub 2017 Jan 6.

13.

Design, methods and demographics from phase I of Alberta's Tomorrow Project cohort: a prospective cohort profile.

Robson PJ, Solbak NM, Haig TR, Whelan HK, Vena JE, Akawung AK, Rosner WK, Brenner DR, Cook LS, Csizmadi I, Kopciuk KA, McGregor SE, Friedenreich CM.

CMAJ Open. 2016 Sep 29;4(3):E515-E527. eCollection 2016 Jul-Sep.

14.

Associations of Postdiagnosis Physical Activity and Change from Prediagnosis Physical Activity with Quality of Life in Prostate Cancer Survivors.

Farris MS, Kopciuk KA, Courneya KS, McGregor SE, Wang Q, Friedenreich CM.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):179-187. doi: 10.1158/1055-9965.EPI-16-0465. Epub 2016 Sep 27.

15.

A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.

Farshidfar F, Weljie AM, Kopciuk KA, Hilsden R, McGregor SE, Buie WD, MacLean A, Vogel HJ, Bathe OF.

Br J Cancer. 2016 Sep 27;115(7):848-57. doi: 10.1038/bjc.2016.243. Epub 2016 Aug 25.

16.

Physical Activity and Survival After Prostate Cancer.

Friedenreich CM, Wang Q, Neilson HK, Kopciuk KA, McGregor SE, Courneya KS.

Eur Urol. 2016 Oct;70(4):576-585. doi: 10.1016/j.eururo.2015.12.032. Epub 2016 Jan 7.

17.

Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes.

Cusulin C, Chesnelong C, Bose P, Bilenky M, Kopciuk K, Chan JA, Cairncross JG, Jones SJ, Marra MA, Luchman HA, Weiss S.

Stem Cell Reports. 2015 Jul 14;5(1):1-9. doi: 10.1016/j.stemcr.2015.05.010. Epub 2015 Jun 18.

18.

Intrapersonal and social environment correlates of leisure-time physical activity for cancer prevention: a cross-sectional study among Canadian adults.

Aparicio-Ting FE, Friedenreich CM, Kopciuk KA, Plotnikoff RC, Bryant HE.

J Phys Act Health. 2014 May;11(4):790-800. doi: 10.1123/jpah.2012-0110.

PMID:
25078523
19.

Identification of prognostic inflammatory factors in colorectal liver metastases.

Hamilton TD, Leugner D, Kopciuk K, Dixon E, Sutherland FR, Bathe OF.

BMC Cancer. 2014 Jul 28;14:542. doi: 10.1186/1471-2407-14-542.

20.

The Sedentary Time and Activity Reporting Questionnaire (STAR-Q): reliability and validity against doubly labeled water and 7-day activity diaries.

Csizmadi I, Neilson HK, Kopciuk KA, Khandwala F, Liu A, Friedenreich CM, Yasui Y, Rabasa-Lhoret R, Bryant HE, Lau DC, Robson PJ.

Am J Epidemiol. 2014 Aug 15;180(4):424-35. doi: 10.1093/aje/kwu150. Epub 2014 Jul 19.

Supplemental Content

Loading ...
Support Center